PATENT CLAIM ANALYSIS

Application Number: 16033690
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "450000"]

Abstract:
Provided, among other things, is a method of treating or ameliorating pulmonary infection in a cystic fibrosis patient comprising pulmonary administration of an effective amount of a liposomal/complexed antiinfective to the patient, wherein the (i) administrated amount is 50% or less of the comparative free drug amount, or (ii) the dosing is once a day or less, or (iii) both.

Claim (Index 13):
The method of treating or ameliorating of  claim 10 , wherein the dosing is once every three days or less.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 95.0
- Lexical Diversity: 1.62222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10696389', '12748756', '13899457', '14319018', '15311488']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6766413678455235
- 35 USC 102 Novelty (BERT): 0.5161605105832131
- Combined Prediction Score: 0.6605932821192926
- Mean Citation Score: 224.913598
- Max Citation Score: 275.5311
- Similarity Product: 174.09624817437532

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test